Sustained Pulmonary Delivery of a Water-Soluble Antibiotic Without Encapsulating Carriers
Authors:
- 27 October 2015
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 33 (3) , 563-572
Abstract
Purpose Traditional polymeric nanoparticle formulations for prolonged local action during inhalation therapy are highly susceptible to muco-ciliary clearance. In addition, polymeric carriers are typically administered in high doses due to finite drug loading. For toxicological reasons, these carriers and their degradation byproducts are undesirable for inhalation therapy, particularly for chronic use, due to potential lung accumulation. Methods We synthesized a novel, insoluble prodrug (MRPD) of a time-dependent β-lactam, meropenem, and formulated MRPD into mucus-penetrating crystals (MRPD-MPCs). After characterizing their mucus mobility (in vitro) and stability, we evaluated the lung pharmacokinetics of intratracheally-instilled MRPD-MPCs and a meropenem solution in guinea pigs. Results Meropenem levels rapidly declined in the lungs of guinea pigs receiving meropenem solution compared to those given MRPD-MPCs. At 9 h after dosing, drug levels in the lungs of animals that received meropenem solution dropped to 12 ng/mL, whereas those that received MRPD-MPCs maintained an average drug level of ≥1,065 ng/mL over a 12-h period. Conclusions This work demonstrated that the combination of prodrug chemistry and mucus-penetrating platform created nanoparticles that produced sustained levels of meropenem in guinea pig lungs. This strategy represents a novel approach for sustained local drug delivery to the lung without using encapsulating matrices.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (R43HL106899)
This publication has 31 references indexed in Scilit:
- Topical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating ParticlesTranslational Vision Science & Technology, 2015
- Delivery strategies for sustained drug release in the lungsAdvanced Drug Delivery Reviews, 2014
- Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrierJournal of Controlled Release, 2014
- Mechanisms of Absorption and Elimination of Drugs Administered By InhalationTherapeutic Delivery, 2013
- A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain TissueScience Translational Medicine, 2012
- Interpretation and prediction of inhaled drug particle accumulation in the lung and its associated toxicityXenobiotica, 2011
- Pulmonary Drug Metabolism, Clearance, and Absorption2011
- Dosimetry and toxicology of inhaled ultrafine particlesBiomarkers, 2009
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissuesAdvanced Drug Delivery Reviews, 2009
- Fate of inhaled particles after interaction with the lung surfacePaediatric Respiratory Reviews, 2006